Halving cancer mortality

Tackling cancer in the developing world

Results from the EURO-SKI cessation trial of TKIs in CML

Mutations associated with imatinib response in CML

CD19 CAR T-cells effective with with low dose chemotherapy.

Causes and consequences of microRNA dysregulation in cancer

Results from SCHOLAR-1 trial for DLBCL patients

Super-enhancer analysis reveals subtypes in AML and MDS

PD-1 enhances elotuzumab efficacy

Novel therapies for older patients with AML and MDS

Karyotyping a CLL subset with ibrutinib susceptibility

Chemo-genomic interrogation reveals JAK sensitive subgroup in AML